Compare SanBio Co., Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 163,870 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.02
-28.24%
12.05
Revenue and Profits:
Net Sales:
(Quarterly Results - Jan 2026)
Net Profit:
-1,129 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
21.79%
0%
21.79%
6 Months
-8.69%
0%
-8.69%
1 Year
-1.48%
0%
-1.48%
2 Years
433.81%
0%
433.81%
3 Years
258.41%
0%
258.41%
4 Years
96.35%
0%
96.35%
5 Years
47.49%
0%
47.49%
SanBio Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
6.76%
EBIT to Interest (avg)
-111.21
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.15
Sales to Capital Employed (avg)
0
Tax Ratio
12.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
324.70
EV to EBIT
-42.95
EV to EBITDA
-43.03
EV to Capital Employed
-1370.97
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-701.71%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jan'26 - YoY
Jan'26
Jan'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1,118.60
-1,031.20
-8.48%
Interest
9.10
2.90
213.79%
Exceptional Items
0.00
9.30
-100.00%
Consolidate Net Profit
-1,128.70
-730.50
-54.51%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Jan 2026 is 0.00% vs 0.00% in Jan 2025
Consolidated Net Profit
YoY Growth in quarter ended Jan 2026 is -54.51% vs 4.05% in Jan 2025
Annual Results Snapshot (Consolidated) - Jan'26
Jan'26
Jan'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-3,786.80
-3,506.70
-7.99%
Interest
81.10
18.90
329.10%
Exceptional Items
0.00
9.30
-100.00%
Consolidate Net Profit
-3,842.60
-2,882.90
-33.29%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Jan 2026 is 0.00% vs 0.00% in Jan 2025
Consolidated Net Profit
YoY Growth in year ended Jan 2026 is -33.29% vs -9.02% in Jan 2025
About SanBio Co., Ltd. 
SanBio Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






